Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03901469
Title A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
Acronym TNBC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Zenith Epigenetics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | BEL


No variant requirements are available.